Allworth Financial LP Buys 4,551 Shares of Synopsys, Inc. $SNPS

Allworth Financial LP grew its stake in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) by 182.1% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,050 shares of the semiconductor company’s stock after purchasing an additional 4,551 shares during the quarter. Allworth Financial LP’s holdings in Synopsys were worth $3,615,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in SNPS. Nuveen LLC bought a new stake in Synopsys in the 1st quarter worth $341,480,000. Pictet Asset Management Holding SA boosted its holdings in shares of Synopsys by 38.3% during the first quarter. Pictet Asset Management Holding SA now owns 2,432,596 shares of the semiconductor company’s stock worth $1,043,518,000 after purchasing an additional 673,837 shares during the period. Generation Investment Management LLP bought a new stake in shares of Synopsys in the first quarter worth about $240,491,000. Vanguard Group Inc. grew its stake in shares of Synopsys by 2.4% in the first quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company’s stock worth $6,359,747,000 after purchasing an additional 346,994 shares during the last quarter. Finally, Alliancebernstein L.P. increased its holdings in Synopsys by 22.2% during the 1st quarter. Alliancebernstein L.P. now owns 1,725,211 shares of the semiconductor company’s stock valued at $739,857,000 after purchasing an additional 313,218 shares during the period. Institutional investors own 85.47% of the company’s stock.

Analyst Ratings Changes

Several research firms have weighed in on SNPS. Mizuho dropped their price objective on Synopsys from $700.00 to $600.00 and set an “outperform” rating for the company in a report on Thursday, September 11th. Wall Street Zen lowered Synopsys from a “hold” rating to a “sell” rating in a research note on Saturday, September 13th. Zacks Research upgraded shares of Synopsys from a “strong sell” rating to a “hold” rating in a report on Monday. JPMorgan Chase & Co. reduced their price objective on shares of Synopsys from $685.00 to $600.00 and set an “overweight” rating on the stock in a research report on Wednesday, September 10th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Synopsys in a research report on Wednesday, October 8th. Nine investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, Synopsys currently has a consensus rating of “Hold” and an average target price of $562.14.

View Our Latest Stock Analysis on Synopsys

Insider Activity

In other news, Director Robert G. Painter purchased 350 shares of Synopsys stock in a transaction that occurred on Thursday, September 11th. The stock was bought at an average price of $425.44 per share, with a total value of $148,904.00. Following the completion of the transaction, the director directly owned 2,291 shares of the company’s stock, valued at approximately $974,683.04. The trade was a 18.03% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Sudhindra Kankanwadi sold 9,873 shares of the company’s stock in a transaction that occurred on Monday, September 22nd. The shares were sold at an average price of $500.90, for a total value of $4,945,385.70. Following the completion of the transaction, the chief accounting officer directly owned 20,520 shares in the company, valued at $10,278,468. This trade represents a 32.48% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 30,894 shares of company stock valued at $16,760,783 over the last ninety days. 0.62% of the stock is currently owned by corporate insiders.

Synopsys Trading Up 0.8%

Synopsys stock opened at $398.81 on Thursday. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $651.73. The company has a market capitalization of $74.08 billion, a price-to-earnings ratio of 31.30, a price-to-earnings-growth ratio of 5.02 and a beta of 1.10. The business’s fifty day simple moving average is $463.30 and its two-hundred day simple moving average is $514.08. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52.

Synopsys (NASDAQ:SNPSGet Free Report) last posted its quarterly earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.75 by ($1.45). The company had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.77 billion. Synopsys had a return on equity of 10.82% and a net margin of 31.04%.Synopsys’s revenue for the quarter was up 14.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $3.43 EPS. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. As a group, equities analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Synopsys Profile

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Featured Articles

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.